Vedisertib (RC48/ADC) Combined With Toripalimab in Bladder-preserving Treatment
Clinical trial NCT07201675 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07201675
- Sponsor
- Qilu Hospital of Shandong University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-01
- Primary completion
- 2027-12-30
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.